• Facebook
  • Twitter
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Cores
  • Community
    • Our Services
    • Core Leadership & Advisory Council
    • Volunteering for a Clinical Trial FAQs
    • How to Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Machine Learning
    • Biomarkers
    • COVID-19
    • ResearchMatch (RM)
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Seminars, Workshops, Media Library
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Clinical and Translational Science Masters and Certificate Programs
    • Enhancing Diversity
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • KL2 & TL1
    • KL2 Mentored Career Development Awards
    • TL1 Predoctoral/Postdoctoral Training Awards
  • Clinical Trials Office
    • CTO About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization

From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization

by William Jester | Nov 18, 2019 | News

The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM).  These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health.  To learn more about the hub.

Recent Posts

  • NJACTS Community Engagement Core Available Services
  • Are You Getting Enough Sleep? Probably Not.
  • Using Artificial Intelligence and Innovative Design to Save Patient’s Lives During the COVID19 Pandemic.
  • NJIT Machine Learning Expert Pan Xu Combats COVID Vaccine Inequity.
  • Join in: “Oh the Possibilities: Careers in Clinical Research” Apr 17, 2023 6:00 pm

Archives

  • 2023
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (1,560)
  • Covid (922)
  • News (1,971)
  • Pilots (18)
Rutgers logo

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)
Contact RU – info at 732-445-info(4636)


  • Facebook

  • Twitter

  • YouTube

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.